Rakesh Popat, Paula Rodríguez Otero
Course Content
Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial
You don't currently have access to this content